Developing a new treatment for safety evaluation and clinical trials.
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL
This study is working on a new treatment called NCGC00413972 to make sure it's safe and effective for people, with the hope that it could offer new options for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10953686 on NIH RePORTER |
What this research studies
This project focuses on the development of a specific compound, NCGC00413972, which involves ensuring its chemistry, manufacturing, and controls are properly established for preclinical safety evaluations and future clinical trials. The research aims to create a reliable and effective treatment option by rigorously testing the compound's safety and efficacy before it is administered to patients. Patients may benefit from this research as it could lead to new therapeutic options once the compound is proven safe and effective.
Who could benefit from this research
Good fit: Ideal candidates for participation would be individuals who are eligible for clinical trials related to the treatment being developed.
Not a fit: Patients who do not meet the eligibility criteria for the clinical trials or those with conditions unrelated to the treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a new treatment that improves patient outcomes.
How similar studies have performed: While the specific compound is novel, similar approaches in developing treatments through rigorous CMC processes have shown success in the past.
Where this research is happening
Albany, United States
- Albany Molecular Research, INC. — Albany, United States (Active)
Researchers
- Principal investigator: Penny, Brian — Albany Molecular Research, INC.
- Study coordinator: Penny, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.